Effect of combined training on breast cancer survivors
Not Applicable
Recruiting
- Conditions
- Multiple Sclerosis (MS).Multiple sclerosis
- Registration Number
- IRCT20150531022498N34
- Lead Sponsor
- Islamic Azad University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 30
Inclusion Criteria
Ability to perform exercise training with oncologist approval
underwent partial mastectomy
termination of chemotherapy
age between 35-50
Exclusion Criteria
More than three consecutive sessions or four intermittent sessions absence from the training
injury during training
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Fasting Blood Sugar. Timepoint: before and after the end of intervention. Method of measurement: Serum levels using Enzymatic method.;CA 15-3 tumor marker. Timepoint: before and after the end of intervention. Method of measurement: Serum levels using Eliza method.;CA 125 tumor marker. Timepoint: before and after the end of intervention. Method of measurement: Serum levels using Eliza method.;CEA tumor marker. Timepoint: before and after the end of intervention. Method of measurement: Serum levels using Eliza method.;Cortisol hormone. Timepoint: before and after the end of intervention. Method of measurement: Serum levels using Eliza method.;Estrogen Hormone. Timepoint: before and after the end of intervention. Method of measurement: Serum levels using Eliza method.;Testosterone Hormone. Timepoint: before and after the end of intervention. Method of measurement: Serum levels using Eliza method.;SHBG. Timepoint: before and after the end of intervention. Method of measurement: Serum levels using Eliza method.
- Secondary Outcome Measures
Name Time Method HbA1C. Timepoint: Before and after the end of interventions. Method of measurement: Serum levels using Enzymatic method.;Insulin hormone. Timepoint: Before and after the end of interventions. Method of measurement: Serum levels using Eliza method.;Leptin hormon. Timepoint: Before and after the end of interventions. Method of measurement: Serum levels using Eliza method.